Salmon calcitonin (Miacalcic NS 200 IU) in prevention of bone loss after hip replacement

Scandinavian Journal of Surgery

Volumn 101, Issue 4, 2012, Pages 249-254

  Arnala, I O ^a  

^a KANTA HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

Bone histomorphometry; Bone loss; Bone mineral density; Calcitonin; Hip replacement; Periprosthetic bone

Indexed keywords

BONE DENSITY CONSERVATION AGENT; CALCITONIN; NOSE SPRAY; SALCATONIN;

CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; INCIDENCE; MALE; OSTEOPOROSIS; PERIPROSTHETIC FRACTURES; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ARTHROPLASTY, REPLACEMENT, HIP; BONE DENSITY CONSERVATION AGENTS; CALCITONIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIP PROSTHESIS; HUMANS; INCIDENCE; MALE; NASAL SPRAYS; OSTEOPOROSIS; PERIPROSTHETIC FRACTURES; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; TREATMENT OUTCOME;

EID: 84873661474     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749691210100405     Document Type: Article

References (27)

1. Santavirta S, Konttinen YT, Bergroth V et al: Aggressive granulomatous lesions associated with hip arthroplasty. J Bone Joint Surg 1990;72-A:252-258
2. Santavirta S, Konttinen YT, Hoikka V et al: Immunopathological response to loose cementless acetabular components. J Bone Joint Surg 1991;73-B:38-42
3. Schmalzried TP, Callaghan JJ: Wear in total hip and knee replacements. J Bone Joint Surg 1999;81-A:115-136
4. Dorr LD, Arnala I, Faugere M-C et al: Five-year postoperative results of cemented femoral arthroplasty in patients with systemic bone disease. Clin Orthop Relat Res 1990;114-121
5. Kanis JA: Pathogenesis of osteoporosis. In Osteoporosis - prevention and control. Blackwell Science Ltd., Oxford, 1994
6. Kannus P, Sievänen H, Vuori I: Physical loading, exercise and bone. Bone 1996;18 (suppl):S1-S3
7. Kröger H, Arnala I, Rehnberg V et al: Histomorphometry in periarticular bone in rheumatoid arthritis Ann Chir Gynaecol 1994;83:56-62
8. Azria M, Copp DH, Zanelli JM: 25 years of salmon calcitonin; from synthesis to therapeutic use. Calcif Tissue Int 1995;57:1-4
9. Stock JL, Avioli LV, Baylink DJ et al: Calcitonin-salmon nasal spray reduces the incidence of new vertebral fractures in postmenopausal women. Three-year interim results of the PROOF study. J Bone Miner Res 1997;12:S149
10. Gruen TA, McNeice GM, Anstutz HC: "Modes of failure" of cemented stem-type femoral components: A radiographic analysis of loosening. Clin Orthop 1979;141:17
11. Malluche HH, Faugere M-C: Atlas of mineralized bone histology, New York, Karger, 1986.
12. Goldner J: A modification of the Masson trichrome technique for routine laboratory purposes. Am J Pathol 1938;14:237-243.
13. Malluche HH, Sherman D, Meyer W et al: A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int 1982;34:439-448
14. Ohlin A, Johnell O, Lerner UH: The pathogenesis of loosening of total hip arthroplasties. The production of factors by periprosthetic tissues that stimulate in vitro bone resorption. Clin Orthop Relat Res 1990;253;287-296
15. Wang W, Ferguson DJ, Quinn JM et al: Biomaterial particle phagosytosis by bone-resorbing osteoclasts. J Bone Joint Surg Br 1997;79:849-856
16. Granchi D, Amato I, Battistelli L et al: Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials 2005;26:2371-2379
17. Peichl P, Griesmacher A, Kumpan W et al: Clinical outcome of salmon calcitonin nasal spray treatment in postmenopausal women after total hip arthroplasty. Gerontology 2005;51:242-251
18. Bhandari M, Bajammal S, Guyatt GH et al: Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am 2005; 87:293-301
19. Lin T, Yan SC, Cai XZ et al: Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials. Osteoporos Int 2012;23:1823-1834
20. Small RE: Uses and limitations of bone mineral density measurements in the management of osteoporosis. Med Gen Med 2005, 7:3
21. Kröger H, Miettinen H, Arnala I et al: Evaluation of periprosthetic bone using dual-energy X-ray absorptiometry: precision of the method and effect of operation on bone mineral density. J Bone Miner Res 1996;11:1526-1530
22. Venesmaa PK, Kröger HP, Jurvelin JS et al: Periprosthetic bone loss after cemented total hip arthroplasty: a prospective 5-year dual energy radiographic absorptiometry study on 15 patients. Acta Orthop Scand 2003;74:31-36
23. Dan D, Germann D, Burki H et al: Bone loss after total hip arthroplasty. Rheumatol Int 2006;26:792-798
24. Buckland AJ, Dowsey MM, Stoney JD et al: Periprosthetic bone remodeling using a triple-taper polished cemented stem in total hip arthjroplasty. Arthroplasty 2010;25:1083-1090.
25. Wilkinson JM, Stockley I, Peel NF et al: Effect of pamidronate on preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial. J Bone Miner Res 2001;16:556-564
26. Arabmothlag M, Rittmeister M, Hennigs T: Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study. J Orthop Res 2006;24:1336-1341
27. Gunal I, Hazer B, Seber S et al: Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients. Acta Orthop Scand 2001;72:467-469